Despite market growth, several challenges remain. Limited awareness in rural populations, lack of trained personnel, inconsistent vaccine availability, and inadequate healthcare infrastructure hinder effective disease control. These factors slow adoption rates and affect market penetration.

To overcome these challenges, stakeholders are focusing on portable diagnostics, community education programs, and government-subsidized vaccination campaigns. These measures are expected to enhance accessibility, improve disease management, and support the Brucellosis Market.

For detailed information, visit the Brucellosis Market.